Video

DDNA19: The NASH conundrum

Publish date: March 20, 2019

 

AT DIGESTIVE DISEASES: NEW ADVANCES 2019

Zobair Younossi, MD, MPH, chairman of the department of medicine at Inova Fairfax (Va.) Medical Campus, discusses the progressive form of NAFLD -- NASH -- and its optimal treatment.

Vidyard Video

Recommended Reading

Women survive more often than men do when hospitalized with cirrhosis
MDedge Internal Medicine
Which biologic is best in Crohn’s? Jury’s still out
MDedge Internal Medicine
Coagulation pathway may play role in IBD
MDedge Internal Medicine
Distinct features found in young-onset CRC
MDedge Internal Medicine
Endoscopic full-thickness resection shows promise in CRC
MDedge Internal Medicine
Dr. Julie Thompson Discusses Primary Biliary Cholangitis
MDedge Internal Medicine
DDNA19: Cardiac Complications in Liver Disease Patients
MDedge Internal Medicine
Will inpatient albumin help in decompensated cirrhosis?
MDedge Internal Medicine
PPI-fracture link can’t be ruled out
MDedge Internal Medicine
Cirrhosis model predicts decompensation across diverse populations
MDedge Internal Medicine